/SNDL
SNDL Stock - SNDL Inc.
Healthcare|Drug Manufacturers - Specialty & GenericNASDAQ
$1.65-0.60%
$0.01 (-0.60%) • Jan 13
71
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.28
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.93
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+185.5%upside
Target: $4.71
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SNDL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.63 – $1.67
TARGET (TP)$4.71
STOP LOSS$1.52
RISK/REWARD1:23.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.67
52W High$2.89
52W Low$1.15
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $920.45M | $909.01M | $712.20M | $56.13M | $60.92M |
| Gross Profit | $240.33M | $190.41M | $140.38M | $-9,001,000 | $-49,869,000 |
| Gross Margin | 26.1% | 20.9% | 19.7% | -16.0% | -81.9% |
| Operating Income | $-103,811,000 | $-163,171,000 | $-347,774,000 | $-134,376,000 | $-185,404,000 |
| Net Income | $-94,796,000 | $-172,660,000 | $-335,114,000 | $-226,984,000 | $-233,246,000 |
| Net Margin | -10.3% | -19.0% | -47.1% | -404.4% | -382.9% |
| EPS | $-0.38 | $-0.65 | $-1.50 | $-1.24 | $-9.50 |
Company Overview
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SNDLBeat Rate
27%
Last 15 quarters
Avg Surprise
-1262.8%
EPS vs Estimate
Beats / Misses
4/11
Last 12 quarters
Latest EPS
$-0.04
Q4 2025
EPS Surprise History
Q1 24
-83.3%
$-0.22vs$-0.12
Q2 24
+75.0%
$-0.01vs$-0.04
Q3 24
+75.0%
$-0.01vs$-0.04
Q4 24
-40.0%
$-0.05vs$-0.04
Q1 25
-1800.0%
$-0.19vs$-0.01
Q2 25
+33.3%
$-0.04vs$-0.06
Q3 25
+125.0%
$0.01vs$-0.04
Q4 25
-11011.1%
$-0.04vs$-0.00
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Mar 17, 2026 | $0.01 | — | — | — |
Q4 2025 | Nov 4, 2025 | $-0.00 | $-0.04 | -11011.1% | ✗ MISS |
Q3 2025 | Jul 31, 2025 | $-0.04 | $0.01 | +125.0% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $-0.06 | $-0.04 | +33.3% | ✓ BEAT |
Q1 2025 | Mar 18, 2025 | $-0.01 | $-0.19 | -1800.0% | ✗ MISS |
Q4 2024 | Nov 5, 2024 | $-0.04 | $-0.05 | -40.0% | ✗ MISS |
Q3 2024 | Aug 1, 2024 | $-0.04 | $-0.01 | +75.0% | ✓ BEAT |
Q2 2024 | May 8, 2024 | $-0.04 | $-0.01 | +75.0% | ✓ BEAT |
Q1 2024 | Mar 20, 2024 | $-0.12 | $-0.22 | -83.3% | ✗ MISS |
Q4 2023 | Nov 13, 2023 | $0.01 | $-0.06 | -915.2% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $0.01 | $-0.08 | -1161.0% | ✗ MISS |
Q2 2023 | May 15, 2023 | $0.01 | $-0.07 | -1047.2% | ✗ MISS |
Q2 2023 | Apr 24, 2023 | $0.01 | $-0.13 | -981.4% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-0.00 | $-0.02 | -925.6% | ✗ MISS |
Q3 2022 | Aug 12, 2022 | $-0.01 | $-0.08 | -985.5% | ✗ MISS |
Q2 2022 | May 16, 2022 | — | $-0.20 | — | — |
Q2 2022 | Apr 27, 2022 | $-0.05 | $-0.20 | -300.0% | ✗ MISS |
Q4 2021 | Nov 11, 2021 | — | $0.10 | — | — |
Q3 2021 | Aug 12, 2021 | — | $0.10 | — | — |
Latest News
Loading news...
Frequently Asked Questions about SNDL
What is SNDL's current stock price?
SNDL Inc. (SNDL) is currently trading at $1.65 per share. The stock has moved -0.60% today.
What is the analyst price target for SNDL?
The average analyst price target for SNDL is $4.71, based on 1 analyst.
What sector is SNDL Inc. in?
SNDL Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the NASDAQ exchange.
What is SNDL's market cap?
SNDL Inc. has a market capitalization of $0.42 billion, making it a small-cap company.
Does SNDL pay dividends?
No, SNDL Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAKBA
Akebia Therapeutics, Inc.
$1.38
Mkt Cap: $0.4B
AQST
Aquestive Therapeutics, Inc.
$3.42
Mkt Cap: $0.3B
CMPS
COMPASS Pathways plc
$7.37
Mkt Cap: $0.7B
CRVS
Corvus Pharmaceuticals, Inc.
$6.50
Mkt Cap: $0.5B
EBS
Emergent BioSolutions Inc.
$12.17
Mkt Cap: $0.7B
EOLS
Evolus, Inc.
$5.72
Mkt Cap: $0.4B
ESPR
Esperion Therapeutics, Inc.
$3.30
Mkt Cap: $0.7B
OLMA
Olema Pharmaceuticals, Inc.
$27.89
Mkt Cap: $1.9B
ORGO
Organogenesis Holdings Inc.
$4.08
Mkt Cap: $0.5B
SIGA
SIGA Technologies, Inc.
$6.60
Mkt Cap: $0.5B
Explore stocks similar to SNDL for comparison